Cancer metastasizes to the bone marrow and not to the bone: time for a paradigm shift! Poul Flemming Høilund-CarlsenSøren HessAbass Alavi Editorial Open access 21 February 2018 Pages: 893 - 897
Imaging αvβ3 integrin expression in skeletal metastases with 99mTc-maraciclatide single-photon emission computed tomography: detection and therapy response assessment Gary J. R. CookGurdip K. AzadVicky Goh Original Article Open access 02 February 2018 Pages: 898 - 903
68Ga-PSMA PET/CT in the evaluation of bone metastases in prostate cancer Christos SachpekidisP. BäumerA. Dimitrakopoulou-Strauss Original Article 23 January 2018 Pages: 904 - 912
PSA-stratified detection rates for [68Ga]THP-PSMA, a novel probe for rapid kit-based 68Ga-labeling and PET imaging, in patients with biochemical recurrence after primary therapy for prostate cancer Thorsten DerlinSebastian SchmuckFrank M. Bengel Original Article 07 January 2018 Pages: 913 - 922
Investigation of receptor radionuclide therapy with 177Lu-DOTATATE in patients with GEP-NEN and a high Ki-67 proliferation index Silvia NicoliniStefano SeveriGiovanni Paganelli Original Article 01 February 2018 Pages: 923 - 930
Ultra-early response assessment in lymphoma treatment: [18F]FDG PET/MR captures changes in glucose metabolism and cell density within the first 72 hours of treatment Marius E. MayerhoeferMarkus RadererAlexander Haug Original Article Open access 26 February 2018 Pages: 931 - 940
Assessment of alteration in liver 18F–FDG uptake due to steatosis in lymphoma patients and its impact on the Deauville score Thibault SalomonCatherine NganoaCharline Lasnon Original Article Open access 26 December 2017 Pages: 941 - 950
Repeatability of quantitative 18F-FLT uptake measurements in solid tumors: an individual patient data multi-center meta-analysis G. M. KramerY. Liuon behalf of the QuIC-ConCePT consortium Original Article Open access 23 January 2018 Pages: 951 - 961
The relationship between local recurrences and distant metastases in prostate cancer: can 11C-choline PET/CT contribute to understand the link? Giampiero GiovacchiniAndrea CiarmielloMaria Picchio Original Article 16 February 2018 Pages: 962 - 969
Prospective observational study of 177Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and impact of a dosimetry-guided study protocol on outcome and toxicity Ulrike Garske-RománMattias SandströmDan Granberg Original Article Open access 01 March 2018 Pages: 970 - 988
Combined model-based and patient-specific dosimetry for 18F-DCFPyL, a PSMA-targeted PET agent Donika PlykuEsther MenaRobert F. Hobbs Original Article 19 February 2018 Pages: 989 - 998
Antitumor effects of radionuclide treatment using α-emitting meta-211At-astato-benzylguanidine in a PC12 pheochromocytoma model Yasuhiro OhshimaHitomi SudoNoriko S. Ishioka Original Article Open access 19 January 2018 Pages: 999 - 1010
11C–acetate PET/CT: a potential alternative of transcranial biopsy for grading cerebral gliomas Jun Hatazawa Editorial Commentary Open access 19 February 2018 Pages: 1011 - 1011
The roles of 11C-acetate PET/CT in predicting tumor differentiation and survival in patients with cerebral glioma Soyoung KimDongwoo KimMijin Yun Original Article 06 March 2018 Pages: 1012 - 1020
Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease Tharick A. PascoalSulantha Mathotaarachchifor the Alzheimer’s Disease Neuroimaging Initiative Original Article Open access 02 February 2018 Pages: 1021 - 1030
Hybrid MR-PET of brain tumours using amino acid PET and chemical exchange saturation transfer MRI N. A. da SilvaP. LohmannN. Jon Shah Original Article 24 February 2018 Pages: 1031 - 1040
A first-in-man PET study of [18F]PSS232, a fluorinated ABP688 derivative for imaging metabotropic glutamate receptor subtype 5 Geoffrey WarnockMichael SommerauerSimon M. Ametamey Original Article 27 November 2017 Pages: 1041 - 1051
Extraction, selection and comparison of features for an effective automated computer-aided diagnosis of Parkinson’s disease based on [123I]FP-CIT SPECT images Francisco P. M. OliveiraDiogo Borges FariaJoão Manuel R. S. Tavares Original Article 23 December 2017 Pages: 1052 - 1062
FDG-PET/CT for treatment response assessment in head and neck squamous cell carcinoma: a systematic review and meta-analysis of diagnostic performance Nils HelsenTim Van den WyngaertSigrid Stroobants Review Article 24 February 2018 Pages: 1063 - 1071
Is it time to change our vision of tumor metabolism prior to immunotherapy? Fabio GrizziAngelo CastelloEgesta Lopci Letter to the Editor 12 March 2018 Pages: 1072 - 1075
Advantage of 18F-PSMA-1007 over 68Ga-PSMA-11 PET imaging for differentiation of local recurrence vs. urinary tracer excretion Kambiz RahbarMatthias WeckesserMartin Bögemann Image of the Month 14 February 2018 Pages: 1076 - 1077
Correction to: Biological tumour volumes of gliomas in early and standard 20–40 min 18F-FET PET images differ according to IDH mutation status M. UnterrainerI. WinkelmannN. L. Albert Correction 15 March 2018 Pages: 1078 - 1078